Rapamycin has dual opposing effects on proteinuric experimental nephropathies: Is it a matter of podocyte damage

Juan Torras, Immaculada Herrero-Fresneda, Oscar Gulias, Maria Flaquer, August Vidal, Josep M. Cruzado, Nuria Lloberas, Marcella Franquesa, Josep M. Grinyó

Producció científica: Article en revista indexadaArticleAvaluat per experts

59 Cites (Scopus)

Resum

Background. In clinical renal transplantation, an increase in proteinuria after conversion from calcineurin inhibitors to rapamycin has been reported. In contrast, there are studies showing a nephro-protective effect of rapamycin in proteinuric diseases characterized by progressive interstitial inflammatory fibrosis.Methods. Because of the contradictory reports concerning rapamycin on proteinuria, we examined proteinuria and podocyte damage markers on two renal disease models, with clearly different pathophysiological mechanisms: a glomerular toxico-immunological model induced by puromycin aminonucleoside, and a chronic hyperfiltration and inflammatory model by mass reduction, both treated with a fixed high rapamycin dose.Results. In puromycin groups, rapamycin provoked significant increases in proteinuria, together with a significant fall in podocin immunofluorescence, as well as clear additional damage to podocyte foot processes. Conversely, after mass reduction, rapamycin produced lower levels of proteinuria and amelioration of inflammatory and pro-fibrotic damage. In contrast to the puromycin model, higher glomerular podocin and nephrin expression and amelioration of glomerular ultrastructural damage were found.Conclusions. We conclude that rapamycin has dual opposing effects on subjacent renal lesion, with proteinuria and podocyte damage aggravation in the glomerular model and a nephro-protective effect in the chronic inflammatory tubulointerstitial model. Rapamycin produces slight alterations in podocyte structure when acting on healthy podocytes, but it clearly worsens those podocytes damaged by other concomitant injury.

Idioma originalAnglès
Pàgines (de-a)3632-3640
Nombre de pàgines9
RevistaNephrology Dialysis Transplantation
Volum24
Número12
DOIs
Estat de la publicacióPublicada - de des. 2009
Publicat externament

Fingerprint

Navegar pels temes de recerca de 'Rapamycin has dual opposing effects on proteinuric experimental nephropathies: Is it a matter of podocyte damage'. Junts formen un fingerprint únic.

Com citar-ho